These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34393512)

  • 1. Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument.
    Koch M; Gräfenstein L; Karnosky J; Schulz C; Koller M
    Cancer Manag Res; 2021; 13():6191-6197. PubMed ID: 34393512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross-cultural, multi-center study.
    Koch M; Hjermstad MJ; Tomaszewski K; Tomaszewska I; Hornslien K; Harle A; Arraras J; Morag O; Pompili C; Ioannidis G; Navarra C; Chie W; Johnson C; Bohrer T; Janssens A; Kulis D; Bottomley A; Schulz C; Zeman F; Koller M
    J Thorac Dis; 2020 Aug; 12(8):4253-4261. PubMed ID: 32944337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender Differences in Symptom Burden, Functional Performance and Global Quality of Life of Lung Cancer Patients Receiving Inpatient versus Outpatient Treatment.
    Koch M; Rothammer T; Rasch F; Müller K; Braess J; Koller M; Schulz C
    Cancer Manag Res; 2023; 15():175-183. PubMed ID: 36852345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
    Hickmann AK; Hechtner M; Nadji-Ohl M; Janko M; Reuter AK; Kohlmann K; Haug M; Grüninger S; Deininger M; Ganslandt O; König J; Wirtz CR; Coburger J; Renovanz M
    J Neurooncol; 2017 Jan; 131(1):135-151. PubMed ID: 27638638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.
    Koller M; Hjermstad MJ; Tomaszewski KA; Tomaszewska IM; Hornslien K; Harle A; Arraras JI; Morag O; Pompili C; Ioannidis G; Georgiou M; Navarra C; Chie WC; Johnson CD; Himpel A; Schulz C; Bohrer T; Janssens A; Kuliś D; Bottomley A
    Ann Oncol; 2017 Nov; 28(11):2874-2881. PubMed ID: 28945875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and adaptation of the EORTC QLQ-LC 29 for use in Chinese patients with lung cancer.
    Dai W; Wang Y; Liu Y; Wei X; Osman AMY; Pompili C; Koller M; Wang Q; Wang Y; Ge J; Xie T; Li Q
    J Patient Rep Outcomes; 2021 Nov; 5(1):122. PubMed ID: 34757501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender Differences in Quality of Life of Metastatic Lung Cancer Patients.
    Koch M; Rasch F; Rothammer T; Müller K; Mohr A; Koller M; Schulz C
    Cancer Manag Res; 2022; 14():2971-2977. PubMed ID: 36238952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
    Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
    Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation and cultural adaptation of EORTC QLQ-LC 29 into Nepalese language for lung cancer patients in Nepal.
    Shrestha S; Shrestha S; Kc B; Sapkota B; Khadka A; Khanal S; Koller M
    J Patient Rep Outcomes; 2020 Jun; 4(1):46. PubMed ID: 32556701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.